Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Software for Malvern’s NanoSight NTA Systems
Friday, July 18, 2014
NTA 3.0 from Malvern improves user experience and enhances performance.

New PAMAS AS3 Autosampling System from PAMAS
Tuesday, July 01, 2014
New particle counting system to analyze high quantities of samples.

Serial Dilution in 96- & 384-well Microplates
Monday, June 30, 2014
INTEGRA has introduced a Row Dilution Plate Holder accessory for its VIAFLO 96 and 384 handheld benchtop pipettes.

Thermo Fisher Scientific Offers HRAM Library for Environmental, Food Safety, Clinical Research, Toxicology
Thursday, June 19, 2014
30,000 MS/MS spectra for 2,000 compounds boost confidence in results, method flexibility

Software Automates Deep Characterization of Biotherapeutic Proteins
Monday, June 16, 2014
A new software tool, Thermo Scientific PepFinder, is designed to increase the speed, quality and accuracy in comprehensive biotherapeutic protein characterization during drug development and production quality control.

HP D300 Offers Speed and Reliability for Drug Titrations at GSK
Wednesday, June 04, 2014
System let scientists to increase throughput for standard drug titrations.

Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
Tuesday, June 03, 2014
Final results demonstrate a very good safety, treatment feasibility and promising signs of efficacy in patients with advanced Soft Tissue Sarcomas.

GE Healthcare Launches Cytiva™ Plus Cardiomyocytes
Wednesday, May 28, 2014
GE’s most biologically relevant human cell model for improved compound safety profiling.

Hepregen Launches First Rat Hepatopac™ Assay Kit
Thursday, May 22, 2014
Application-directed kit complements its human kit counterpart.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 638
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv